Tel Aviv, Israel

Arye Friedrich

This inventor holds 1 USPTO granted patent. Top assignee: Fitto Ltd. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arye Friedrich. Retrieved from https://idiyas.com/inventor/arye-friedrich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arye Friedrich: Innovator in Collapsible Capsule Technology

Introduction

Arye Friedrich is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of capsule technology, particularly with his innovative designs that enhance functionality and usability.

Latest Patents

Friedrich holds a patent for "Collapsible capsules and supplemental devices." This invention features a collapsible capsule that includes a first annular body portion with an opening at its proximal end and a second annular body portion that is smaller in diameter. The design allows for efficient storage and transport, making it a valuable addition to the industry.

Career Highlights

Arye Friedrich is currently associated with Fitto Ltd., where he continues to develop and refine his innovative ideas. His work focuses on creating practical solutions that address real-world challenges in capsule design.

Collaborations

Friedrich collaborates with Yaniv Lavi, leveraging their combined expertise to push the boundaries of capsule technology.

Conclusion

Arye Friedrich's contributions to the field of collapsible capsules demonstrate his commitment to innovation and practicality. His work at Fitto Ltd. continues to pave the way for advancements in this area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…